| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 4.55e-11 | 46 | 56 | 7 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 9.21e-07 | 188 | 56 | 7 | GO:0005201 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 2.43e-10 | 63 | 53 | 7 | GO:0033120 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 1.41e-09 | 44 | 53 | 6 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 2.76e-09 | 49 | 53 | 6 | GO:0050685 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 3.86e-08 | 129 | 53 | 7 | GO:0048024 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 5.41e-08 | 207 | 53 | 8 | GO:0043484 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.55e-07 | 158 | 53 | 7 | GO:0050684 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | SETD1A ADRA2A TTBK1 HMGA2 CEBPE CCM2L RBM10 RBMY1A1 RBMY1C RBMY1F EIF4G1 RBMY1D RBMY1B RBMY1E SMN1 | 2.23e-06 | 1446 | 53 | 15 | GO:0010628 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 3.42e-06 | 358 | 53 | 8 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 3.42e-06 | 358 | 53 | 8 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 3.71e-06 | 362 | 53 | 8 | GO:0000375 | |
| GeneOntologyBiologicalProcess | RNA splicing | 3.94e-05 | 502 | 53 | 8 | GO:0008380 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 4.82e-05 | 377 | 53 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 4.90e-05 | 378 | 53 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 4.98e-05 | 379 | 53 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 5.18e-05 | 259 | 53 | 6 | GO:1903313 | |
| GeneOntologyBiologicalProcess | mRNA processing | 7.58e-05 | 551 | 53 | 8 | GO:0006397 | |
| GeneOntologyBiologicalProcess | male gonad development | 7.68e-05 | 171 | 53 | 5 | GO:0008584 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 7.90e-05 | 172 | 53 | 5 | GO:0046546 | |
| GeneOntologyBiologicalProcess | endodermal cell differentiation | 1.27e-04 | 38 | 53 | 3 | GO:0035987 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.32e-04 | 443 | 53 | 7 | GO:1903311 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 1.49e-04 | 197 | 53 | 5 | GO:0002244 | |
| GeneOntologyBiologicalProcess | male sex differentiation | 1.57e-04 | 199 | 53 | 5 | GO:0046661 | |
| GeneOntologyBiologicalProcess | endoderm formation | 2.71e-04 | 49 | 53 | 3 | GO:0001706 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 2.88e-04 | 10 | 53 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 2.90e-04 | 124 | 53 | 4 | GO:0001704 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 4.21e-04 | 12 | 53 | 2 | GO:0038063 | |
| GeneOntologyBiologicalProcess | regulation of erythrocyte differentiation | 4.94e-04 | 60 | 53 | 3 | GO:0045646 | |
| GeneOntologyBiologicalProcess | neural crest formation | 8.60e-04 | 17 | 53 | 2 | GO:0014029 | |
| GeneOntologyBiologicalProcess | gonad development | 9.05e-04 | 292 | 53 | 5 | GO:0008406 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 9.65e-04 | 18 | 53 | 2 | GO:0038065 | |
| GeneOntologyBiologicalProcess | sperm DNA condensation | 9.65e-04 | 18 | 53 | 2 | GO:0035092 | |
| GeneOntologyBiologicalProcess | hemopoiesis | EOMES SOX12 SETD1A CEBPE ABCB10 INPP5D RBMY1A1 RBMY1D RBMY1B RBMY1E | 9.75e-04 | 1223 | 53 | 10 | GO:0030097 |
| GeneOntologyBiologicalProcess | development of primary sexual characteristics | 9.76e-04 | 297 | 53 | 5 | GO:0045137 | |
| GeneOntologyCellularComponent | collagen trimer | COL4A1 COL4A3 COL4A4 COL5A2 C1QL2 COL9A3 COL19A1 C1QL4 COL25A1 | 1.76e-12 | 88 | 56 | 9 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 2.67e-07 | 21 | 56 | 4 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 3.62e-07 | 6 | 56 | 3 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.01e-06 | 8 | 56 | 3 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.01e-06 | 8 | 56 | 3 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.01e-06 | 8 | 56 | 3 | GO:0098645 | |
| GeneOntologyCellularComponent | male germ cell nucleus | 3.39e-06 | 86 | 56 | 5 | GO:0001673 | |
| GeneOntologyCellularComponent | germ cell nucleus | 1.29e-05 | 113 | 56 | 5 | GO:0043073 | |
| GeneOntologyCellularComponent | spliceosomal complex | 2.33e-05 | 215 | 56 | 6 | GO:0005681 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.85e-05 | 332 | 56 | 7 | GO:0005788 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 5.12e-04 | 530 | 56 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SETD1A CEBPE POLD1 RBMY1A1 RBMY1C SENP3 RBMY1F RBMY1D RBMY1B RBMY1E RFX5 | 9.27e-04 | 1377 | 56 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | extracellular matrix | 1.77e-03 | 656 | 56 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.80e-03 | 658 | 56 | 7 | GO:0030312 | |
| HumanPheno | Glomerular basement membrane lamellation | 5.33e-05 | 3 | 22 | 2 | HP:0030034 | |
| HumanPheno | Thin glomerular basement membrane | 5.33e-05 | 3 | 22 | 2 | HP:0012577 | |
| MousePheno | hematuria | 2.36e-05 | 19 | 42 | 3 | MP:0005161 | |
| Domain | Collagen | COL4A1 COL4A3 COL4A4 COL5A2 C1QL2 COL9A3 COL19A1 C1QL4 COL25A1 | 2.91e-12 | 85 | 55 | 9 | PF01391 |
| Domain | Collagen | COL4A1 COL4A3 COL4A4 COL5A2 C1QL2 COL9A3 COL19A1 C1QL4 COL25A1 | 2.91e-12 | 85 | 55 | 9 | IPR008160 |
| Domain | RBM1CTR | 1.02e-11 | 8 | 55 | 5 | PF08081 | |
| Domain | RBM1CTR | 1.02e-11 | 8 | 55 | 5 | IPR012604 | |
| Domain | RRM_1 | 1.61e-07 | 208 | 55 | 8 | PF00076 | |
| Domain | RRM | 2.22e-07 | 217 | 55 | 8 | SM00360 | |
| Domain | RRM_dom | 3.13e-07 | 227 | 55 | 8 | IPR000504 | |
| Domain | RRM | 3.46e-07 | 230 | 55 | 8 | PS50102 | |
| Domain | C4 | 4.80e-07 | 6 | 55 | 3 | SM00111 | |
| Domain | - | 4.80e-07 | 6 | 55 | 3 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 4.80e-07 | 6 | 55 | 3 | IPR001442 | |
| Domain | NC1_IV | 4.80e-07 | 6 | 55 | 3 | PS51403 | |
| Domain | C4 | 4.80e-07 | 6 | 55 | 3 | PF01413 | |
| Domain | Nucleotide-bd_a/b_plait | 8.26e-07 | 258 | 55 | 8 | IPR012677 | |
| Domain | - | 7.09e-06 | 244 | 55 | 7 | 3.30.70.330 | |
| Domain | HMGI/Y_DNA-bd_CS | 1.02e-04 | 31 | 55 | 3 | IPR000637 | |
| Domain | C1q_dom | 1.36e-04 | 34 | 55 | 3 | IPR001073 | |
| Domain | C1Q | 1.36e-04 | 34 | 55 | 3 | PS50871 | |
| Domain | - | 4.29e-04 | 50 | 55 | 3 | 2.60.120.40 | |
| Domain | Tumour_necrosis_fac-like_dom | 6.65e-04 | 58 | 55 | 3 | IPR008983 | |
| Domain | AT_hook | 9.95e-04 | 16 | 55 | 2 | PF02178 | |
| Domain | AT_hook | 2.85e-03 | 27 | 55 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.85e-03 | 27 | 55 | 2 | IPR017956 | |
| Domain | VWC | 3.06e-03 | 28 | 55 | 2 | PF00093 | |
| Domain | CTDL_fold | 3.86e-03 | 107 | 55 | 3 | IPR016187 | |
| Domain | C1Q | 3.99e-03 | 32 | 55 | 2 | SM00110 | |
| Domain | C1q | 3.99e-03 | 32 | 55 | 2 | PF00386 | |
| Domain | VWFC_1 | 5.03e-03 | 36 | 55 | 2 | PS01208 | |
| Domain | VWC | 5.59e-03 | 38 | 55 | 2 | SM00214 | |
| Domain | VWFC_2 | 5.59e-03 | 38 | 55 | 2 | PS50184 | |
| Domain | VWF_dom | 6.80e-03 | 42 | 55 | 2 | IPR001007 | |
| Domain | - | 8.46e-03 | 47 | 55 | 2 | 3.30.420.10 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.47e-11 | 41 | 39 | 7 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.50e-11 | 44 | 39 | 7 | M27812 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.75e-10 | 61 | 39 | 7 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.89e-10 | 64 | 39 | 7 | M26953 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 5.42e-10 | 67 | 39 | 7 | M26999 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.34e-09 | 76 | 39 | 7 | MM14573 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.87e-09 | 20 | 39 | 5 | MM15061 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.44e-09 | 90 | 39 | 7 | M631 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 6.26e-09 | 53 | 39 | 6 | MM14566 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 5.83e-08 | 38 | 39 | 5 | MM14969 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 9.67e-08 | 140 | 39 | 7 | M587 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 9.81e-08 | 42 | 39 | 5 | M7169 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.57e-07 | 46 | 39 | 5 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.40e-07 | 50 | 39 | 5 | MM14796 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.68e-07 | 57 | 39 | 5 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 5.11e-07 | 58 | 39 | 5 | M2049 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.43e-07 | 114 | 39 | 6 | MM14571 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 6.60e-07 | 61 | 39 | 5 | M27103 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 7.77e-07 | 63 | 39 | 5 | M11187 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.70e-06 | 32 | 39 | 4 | MM14924 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.74e-06 | 74 | 39 | 5 | M160 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.99e-06 | 76 | 39 | 5 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.99e-06 | 76 | 39 | 5 | MM14867 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.32e-06 | 10 | 39 | 3 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.32e-06 | 10 | 39 | 3 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 3.18e-06 | 11 | 39 | 3 | M15422 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.47e-06 | 85 | 39 | 5 | M16441 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 4.23e-06 | 12 | 39 | 3 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 5.49e-06 | 13 | 39 | 3 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 5.49e-06 | 13 | 39 | 3 | M12950 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.91e-06 | 258 | 39 | 7 | MM14572 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 6.98e-06 | 14 | 39 | 3 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 6.98e-06 | 14 | 39 | 3 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 8.71e-06 | 15 | 39 | 3 | MM14922 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 8.71e-06 | 15 | 39 | 3 | M27161 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.55e-05 | 18 | 39 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.55e-05 | 18 | 39 | 3 | MM14882 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.58e-05 | 300 | 39 | 7 | M610 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.04e-05 | 59 | 39 | 4 | M27218 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 2.16e-05 | 20 | 39 | 3 | M15394 | |
| Pathway | WP_MRNA_PROCESSING | 2.65e-05 | 451 | 39 | 8 | MM15946 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 3.19e-05 | 66 | 39 | 4 | M18 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 3.34e-05 | 23 | 39 | 3 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 3.34e-05 | 23 | 39 | 3 | MM1427 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.55e-05 | 30 | 39 | 3 | M27216 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.24e-04 | 43 | 39 | 3 | M53 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 7.20e-04 | 261 | 39 | 5 | MM15676 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 8.93e-04 | 575 | 39 | 7 | M29853 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.60e-03 | 84 | 39 | 3 | M7098 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 2.34e-03 | 96 | 39 | 3 | M39834 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 3.96e-03 | 34 | 39 | 2 | M42555 | |
| Pubmed | 9.24e-17 | 7 | 56 | 6 | 8269511 | ||
| Pubmed | 1.21e-14 | 12 | 56 | 6 | 9598316 | ||
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 15184870 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 1.89e-13 | 7 | 56 | 5 | 8875892 | |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 3.01e-11 | 5 | 56 | 4 | 8817321 | |
| Pubmed | 3.01e-11 | 5 | 56 | 4 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 3.01e-11 | 5 | 56 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 3.01e-11 | 5 | 56 | 4 | 19737860 | |
| Pubmed | 9.02e-11 | 6 | 56 | 4 | 18239052 | ||
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 9.02e-11 | 6 | 56 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 9.02e-11 | 6 | 56 | 4 | 12356914 | |
| Pubmed | 9.02e-11 | 6 | 56 | 4 | 9499427 | ||
| Pubmed | 9.02e-11 | 6 | 56 | 4 | 15051956 | ||
| Pubmed | 2.10e-10 | 7 | 56 | 4 | 17001072 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 2.10e-10 | 7 | 56 | 4 | 10377282 | |
| Pubmed | 4.20e-10 | 8 | 56 | 4 | 7479793 | ||
| Pubmed | 1.26e-09 | 10 | 56 | 4 | 10601091 | ||
| Pubmed | 1.26e-09 | 10 | 56 | 4 | 9384609 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 2.95e-09 | 12 | 56 | 4 | 20543856 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 4.26e-09 | 13 | 56 | 4 | 23816659 | |
| Pubmed | 4.26e-09 | 13 | 56 | 4 | 10749975 | ||
| Pubmed | 5.38e-09 | 153 | 56 | 7 | 25037231 | ||
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 5.96e-09 | 14 | 56 | 4 | 14611631 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 8.12e-09 | 15 | 56 | 4 | 14762062 | |
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 1.41e-08 | 17 | 56 | 4 | 28115466 | |
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 1.58e-08 | 4 | 56 | 3 | 7827955 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 1.81e-08 | 18 | 56 | 4 | 12023983 | |
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 9409248 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 7.88e-08 | 6 | 56 | 3 | 9506531 | |
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 7495302 | ||
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 7.88e-08 | 6 | 56 | 3 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 7.88e-08 | 6 | 56 | 3 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 7.88e-08 | 6 | 56 | 3 | 6389236 | |
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 7.88e-08 | 6 | 56 | 3 | 10534397 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 7.88e-08 | 6 | 56 | 3 | 9673377 | |
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 7.88e-08 | 6 | 56 | 3 | 19275937 | |
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 6988303 | ||
| Pubmed | 8.77e-08 | 26 | 56 | 4 | 35920200 | ||
| Pubmed | 1.38e-07 | 7 | 56 | 3 | 10639489 | ||
| Pubmed | 1.38e-07 | 7 | 56 | 3 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 1.38e-07 | 7 | 56 | 3 | 8006028 | |
| Pubmed | 1.38e-07 | 7 | 56 | 3 | 10416788 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 1.38e-07 | 7 | 56 | 3 | 10716744 | |
| Pubmed | 1.38e-07 | 7 | 56 | 3 | 1724753 | ||
| Pubmed | 1.38e-07 | 7 | 56 | 3 | 7521231 | ||
| Pubmed | 2.20e-07 | 8 | 56 | 3 | 3997552 | ||
| Pubmed | 2.20e-07 | 8 | 56 | 3 | 29422532 | ||
| Pubmed | 2.20e-07 | 8 | 56 | 3 | 1383086 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 2.20e-07 | 8 | 56 | 3 | 11867580 | |
| Pubmed | 2.20e-07 | 8 | 56 | 3 | 10382266 | ||
| Pubmed | 3.30e-07 | 9 | 56 | 3 | 8562707 | ||
| Pubmed | 3.30e-07 | 9 | 56 | 3 | 10880400 | ||
| Pubmed | 3.30e-07 | 9 | 56 | 3 | 8995276 | ||
| Pubmed | 3.30e-07 | 9 | 56 | 3 | 9878537 | ||
| Pubmed | 3.30e-07 | 9 | 56 | 3 | 12101409 | ||
| Pubmed | 4.71e-07 | 10 | 56 | 3 | 9415455 | ||
| Pubmed | 4.71e-07 | 10 | 56 | 3 | 9136074 | ||
| Pubmed | 6.46e-07 | 11 | 56 | 3 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 6.46e-07 | 11 | 56 | 3 | 7500359 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 6.46e-07 | 11 | 56 | 3 | 9731539 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 8.61e-07 | 12 | 56 | 3 | 12180907 | |
| Pubmed | 8.61e-07 | 12 | 56 | 3 | 8918877 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 8.61e-07 | 12 | 56 | 3 | 15837576 | |
| Pubmed | 8.61e-07 | 12 | 56 | 3 | 16024816 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 1.12e-06 | 13 | 56 | 3 | 9833687 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.26e-06 | 341 | 56 | 7 | 32971831 | |
| Pubmed | 1.41e-06 | 347 | 56 | 7 | 16033648 | ||
| Pubmed | 1.42e-06 | 14 | 56 | 3 | 12878203 | ||
| Pubmed | 1.77e-06 | 15 | 56 | 3 | 10625553 | ||
| Pubmed | 1.77e-06 | 15 | 56 | 3 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 1.77e-06 | 15 | 56 | 3 | 10706142 | |
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.93e-06 | 55 | 56 | 4 | 19468303 | |
| Pubmed | 2.18e-06 | 16 | 56 | 3 | 15878328 | ||
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 2.55e-06 | 2 | 56 | 2 | 32473614 | |
| Pubmed | Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family. | 2.55e-06 | 2 | 56 | 2 | 28674241 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 9537506 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 7987396 | ||
| Pubmed | Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? | 2.55e-06 | 2 | 56 | 2 | 35090027 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 29742505 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 38214412 | ||
| Pubmed | Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. | 2.55e-06 | 2 | 56 | 2 | 17216251 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 35369551 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 25307543 | ||
| Pubmed | Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. | 2.55e-06 | 2 | 56 | 2 | 27281700 | |
| Pubmed | [From Alport syndrome to benign familial hematuria: clinical and genetic aspect]. | 2.55e-06 | 2 | 56 | 2 | 16895672 | |
| Pubmed | COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. | 2.55e-06 | 2 | 56 | 2 | 24052634 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 19357112 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12768082 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 25229338 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 17942953 | ||
| Pubmed | Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus. | 2.55e-06 | 2 | 56 | 2 | 20029656 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 32574725 | ||
| Pubmed | Persistent familial hematuria in children and the locus for thin basement membrane nephropathy. | 2.55e-06 | 2 | 56 | 2 | 16235097 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 25381091 | ||
| Pubmed | Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. | 2.55e-06 | 2 | 56 | 2 | 15280517 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15880327 | ||
| Pubmed | Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing. | 2.55e-06 | 2 | 56 | 2 | 35386907 | |
| Interaction | RBMY1F interactions | 2.74e-06 | 36 | 55 | 4 | int:RBMY1F | |
| Interaction | HABP2 interactions | 1.52e-05 | 18 | 55 | 3 | int:HABP2 | |
| Interaction | OSM interactions | 2.12e-05 | 20 | 55 | 3 | int:OSM | |
| Interaction | ZNF317 interactions | 2.79e-05 | 64 | 55 | 4 | int:ZNF317 | |
| Interaction | CDCA8 interactions | 3.10e-05 | 133 | 55 | 5 | int:CDCA8 | |
| Interaction | TGFBI interactions | 4.24e-05 | 25 | 55 | 3 | int:TGFBI | |
| Interaction | RBMY1E interactions | 4.37e-05 | 4 | 55 | 2 | int:RBMY1E | |
| Interaction | RBMY1J interactions | 6.68e-05 | 29 | 55 | 3 | int:RBMY1J | |
| Cytoband | Yq11.223 | 1.08e-07 | 93 | 56 | 5 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 3.98e-05 | 311 | 56 | 5 | chrYq11 | |
| Cytoband | 3q27 | 4.31e-04 | 25 | 56 | 2 | 3q27 | |
| Cytoband | 12q13.12 | 9.99e-04 | 38 | 56 | 2 | 12q13.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.79e-03 | 423 | 56 | 4 | chr12q13 | |
| Cytoband | 19q13.3 | 4.56e-03 | 82 | 56 | 2 | 19q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 4.89e-03 | 85 | 56 | 2 | chr2q36 | |
| GeneFamily | Collagens | 1.53e-11 | 46 | 44 | 7 | 490 | |
| GeneFamily | RNA binding motif containing | SETD1A RBM10 RBMY1A1 RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E RAVER1 | 1.83e-09 | 213 | 44 | 9 | 725 |
| GeneFamily | Endogenous ligands|C1q and TNF related | 1.07e-05 | 18 | 44 | 3 | 1372 | |
| Coexpression | NABA_COLLAGENS | 3.66e-12 | 43 | 55 | 7 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 4.35e-12 | 44 | 55 | 7 | M3005 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 6.78e-07 | 33 | 55 | 4 | MM701 | |
| Coexpression | NABA_CORE_MATRISOME | 1.51e-06 | 270 | 55 | 7 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.71e-06 | 275 | 55 | 7 | M5884 | |
| Coexpression | ZHENG_IL22_SIGNALING_DN | 2.42e-06 | 45 | 55 | 4 | MM763 | |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A3 COL4A4 COL5A2 C1QL2 COL9A3 COL19A1 CHRD C1QL4 COL25A1 C1QTNF12 | 6.53e-06 | 1008 | 55 | 11 | MM17056 |
| Coexpression | HAY_BONE_MARROW_FOLLICULAR_B_CELL | 1.22e-05 | 142 | 55 | 5 | M39198 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.50e-05 | 23 | 55 | 3 | M48001 | |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A3 COL4A4 COL5A2 C1QL2 COL9A3 COL19A1 CHRD C1QL4 COL25A1 | 4.76e-05 | 1026 | 55 | 10 | M5889 |
| Coexpression | PATIL_LIVER_CANCER | 6.64e-05 | 660 | 55 | 8 | M1195 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 8.18e-05 | 40 | 55 | 3 | M5887 | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-06 | 187 | 53 | 5 | 908df5520142d65fe32a003d26be14965082a1ea | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-06 | 187 | 53 | 5 | c1dfab0b0d7f519b9f13f4e0365ab41c4b2ae1ec | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-06 | 187 | 53 | 5 | b486cc5ac678051fea9d4c7db53b26a5a8427e60 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-06 | 188 | 53 | 5 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.18e-06 | 191 | 53 | 5 | b7d17d3ba488378b30f3732f8109f4a7c1673e61 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-06 | 198 | 53 | 5 | b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.89e-06 | 199 | 53 | 5 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.89e-06 | 199 | 53 | 5 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.23e-05 | 119 | 53 | 4 | d8fbea9ded96fcc3ebdfb4d28873c563427ce811 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.23e-05 | 119 | 53 | 4 | 9e38f13bf98b9ee44b178300e6f80fd08a006296 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.06e-05 | 150 | 53 | 4 | 4bdcdce40f54580c7a4e1416b468e657ba8874fc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-05 | 162 | 53 | 4 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-05 | 162 | 53 | 4 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nxph3-Excitatory_Neuron.Slc17a7-Slc17a6.Nxph3-Cbln2-Htr2c_(Deep_layer_subiculum)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.32e-05 | 57 | 53 | 3 | 35494ca30bdafb4c175d74f0b4892098411784b0 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 4.76e-05 | 168 | 53 | 4 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | IIH-naiveBc|IIH / Condition, Cell_class and T cell subcluster | 4.76e-05 | 168 | 53 | 4 | 8450ed6720d308c711dfbc76652e5821be7b8e93 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.76e-05 | 168 | 53 | 4 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 4.76e-05 | 168 | 53 | 4 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | IIH-naiveBc-|IIH / Condition, Cell_class and T cell subcluster | 4.76e-05 | 168 | 53 | 4 | 27b500f79aedc4669988670c92ff1a47dcbdf2a0 | |
| ToppCell | droplet-Fat-Bat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-05 | 170 | 53 | 4 | c720d81bc29a8fd1f1249c6af408471d561f1d5d | |
| ToppCell | droplet-Fat-Bat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-05 | 170 | 53 | 4 | c4ecdfc2b4710da0a5fbb20e9df02536023badb1 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue | 5.10e-05 | 171 | 53 | 4 | 9ecef653f6916572bf5fbee5aea6c577d04e96ba | |
| ToppCell | IIF-Lymphocyte-B-B_intermediate|IIF / Disease, Lineage and Cell Type | 5.58e-05 | 175 | 53 | 4 | 327f8ee3669c3fc5ba50abc3b4f3e068637fd8d8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.83e-05 | 177 | 53 | 4 | aef050784abbba45c4ab4e8328339c8739c5c453 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.83e-05 | 177 | 53 | 4 | 320fd77c7c98e9305dcc34a168ec9d674539ed65 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-05 | 178 | 53 | 4 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 6.23e-05 | 180 | 53 | 4 | 237a2130a3f48595dad2417539c21e44585962b8 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 6.50e-05 | 182 | 53 | 4 | 310f94437d197eaaaf6e30e68063b33e94befe77 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.50e-05 | 182 | 53 | 4 | ccd729388d997cc45071175cb0c3db6d0790eaf8 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.64e-05 | 183 | 53 | 4 | ffa831f67ed005f05d1b80ebc707e046fc08e22f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.78e-05 | 184 | 53 | 4 | d18e94839a62fca536ae1630c154e5d0aafc44c5 | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.92e-05 | 185 | 53 | 4 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | moderate-Lymphoid-B_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.07e-05 | 186 | 53 | 4 | fd2c4c3e8929ca5d64f6c5064e5f3d3d6ba07b5f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.37e-05 | 188 | 53 | 4 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.52e-05 | 189 | 53 | 4 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.52e-05 | 189 | 53 | 4 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | 10x5'-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 7.52e-05 | 189 | 53 | 4 | 9837dca502c9a7f42efb0bc74f3e88e7461e7dc8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.68e-05 | 190 | 53 | 4 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.68e-05 | 190 | 53 | 4 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.68e-05 | 190 | 53 | 4 | 136ca6da77a202874376af193a1dd71d810c76c4 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.68e-05 | 190 | 53 | 4 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | Control-Lymphoid_B-B_intermediate|Control / Disease group, lineage and cell class | 7.83e-05 | 191 | 53 | 4 | 0082181dbc39c7c4fd3aa34c3ed61439548e844b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-05 | 191 | 53 | 4 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.83e-05 | 191 | 53 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.83e-05 | 191 | 53 | 4 | 5a9a592875fbd0b1429b48db29a760fdc9c2c856 | |
| ToppCell | B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.83e-05 | 191 | 53 | 4 | 72e3191990973440e4f91427208df360f73e4f41 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-05 | 192 | 53 | 4 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.99e-05 | 192 | 53 | 4 | 0bda96d8f223e8fa9caf935079ab202fc5c812ee | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 7.99e-05 | 192 | 53 | 4 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.99e-05 | 192 | 53 | 4 | f9f64ad7bab1433e9a45adb7db7f43ce3f591b47 | |
| ToppCell | B_cells-Memory_B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.99e-05 | 192 | 53 | 4 | eef591095921ede098f41a2b81897b18915bb753 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.99e-05 | 192 | 53 | 4 | 4884fd8ffa6fd6c30d7ac6bf447456b3397eabc5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.99e-05 | 192 | 53 | 4 | 89b8ebdc285ed3c0f807fd1157271130d37dfa41 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-05 | 192 | 53 | 4 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | Healthy/Control-B_intermediate|World / Disease group and Cell class | 7.99e-05 | 192 | 53 | 4 | 2266aa695955f5d885708e6bc0d5a8827c306223 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.15e-05 | 193 | 53 | 4 | 8f1d6024ef092923321e6efd441b8d476db70aed | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 8.15e-05 | 193 | 53 | 4 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.15e-05 | 193 | 53 | 4 | 749faa5c592ee354733f5a7363a4277ef3462b93 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.32e-05 | 194 | 53 | 4 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 8.32e-05 | 194 | 53 | 4 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.32e-05 | 194 | 53 | 4 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | Control-Lymphoid-Plasma,_B_cells|Control / Condition, Lineage and Cell class | 8.32e-05 | 194 | 53 | 4 | 31fff4361ebed6308b1e6b2b705ee6e0a695bd0c | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_intermediate|COVID-19_Mild / Disease group, lineage and cell class | 8.32e-05 | 194 | 53 | 4 | bf6f72a489c62cbf1a679552d8c5eaaaa0b99d33 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 8.32e-05 | 194 | 53 | 4 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.32e-05 | 194 | 53 | 4 | f0c113edb706d53792892115b67277a285219942 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.32e-05 | 194 | 53 | 4 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | IPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 8.32e-05 | 194 | 53 | 4 | 1a41da29d5adaf766a84eff0003b959e4523f7f1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.49e-05 | 195 | 53 | 4 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-05 | 195 | 53 | 4 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.49e-05 | 195 | 53 | 4 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.49e-05 | 195 | 53 | 4 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.49e-05 | 195 | 53 | 4 | 98ca9f3aa36211dde1e6f7f3817b9418c95e583e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-05 | 195 | 53 | 4 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 8.65e-05 | 196 | 53 | 4 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B|lymph-node_spleen / Manually curated celltypes from each tissue | 8.83e-05 | 197 | 53 | 4 | 9837bd2cc28b79147fb5d1997631ef953fd020e4 | |
| ToppCell | severe_COVID-19-B_intermediate|severe_COVID-19 / disease group, cell group and cell class (v2) | 8.83e-05 | 197 | 53 | 4 | 3ba64850b344cb24a4d20d64392a0b2752950d40 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 197 | 53 | 4 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 197 | 53 | 4 | 0e56255862fed099e771ebd2529393dc5a3641ba | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 197 | 53 | 4 | da175e66d0a743a1b91d46f224b5ff1d37aa5410 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-B_cells|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.00e-05 | 198 | 53 | 4 | 6231c44a909dd06f85c8210814e976a5f29148d0 | |
| ToppCell | MS-IIF-Lymphocyte-B-B_intermediate|IIF / Disease, condition lineage and cell class | 9.00e-05 | 198 | 53 | 4 | d6b533c5e1d55e13b1e87ce3dbacb1564bcdcc64 | |
| ToppCell | control-B_intermediate|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.00e-05 | 198 | 53 | 4 | e24345c8cec8c21f7b5163b7326ba8f83a587ce3 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_intermediate|COVID-19_Mild / Disease, condition lineage and cell class | 9.18e-05 | 199 | 53 | 4 | 1c6a08d01f6c1a2a4b6587d3a4522efbd03275e1 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 9.18e-05 | 199 | 53 | 4 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | Control-Control-Lymphocyte-B-B_intermediate|Control / Disease, condition lineage and cell class | 9.18e-05 | 199 | 53 | 4 | ee6f07eec7edfe41d2f7fcb0b509ce00e99a6a95 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.36e-05 | 200 | 53 | 4 | ca5401b76ab014080914bf78042d368cf318effa | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.36e-05 | 200 | 53 | 4 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | severe-B_intermediate|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.36e-05 | 200 | 53 | 4 | 6d0ac3d00400dd5657ee266f7b885381bf790ce1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.36e-05 | 200 | 53 | 4 | 70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.36e-05 | 200 | 53 | 4 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.36e-05 | 200 | 53 | 4 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.36e-05 | 200 | 53 | 4 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.36e-05 | 200 | 53 | 4 | 40286010bd17cf9e34ecd5440953b072ebfae208 | |
| ToppCell | mild-B_intermediate|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.36e-05 | 200 | 53 | 4 | 8e3132a1fe3708f725c5c4077878fb87bbea3678 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.36e-05 | 200 | 53 | 4 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | severe_influenza-B_cell|World / disease group, cell group and cell class (v2) | 1.47e-04 | 86 | 53 | 3 | 7b595bcba4bcb72b7de7c06e19f690f0c739c529 | |
| ToppCell | droplet-Fat-Scat-21m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 92 | 53 | 3 | 246aebf5f17d50f67a7b48f713ea5043cefefb24 | |
| ToppCell | droplet-Fat-Scat-21m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 97 | 53 | 3 | 440d45ecfc9b66cb61d734118601e745892d51e3 | |
| ToppCell | droplet-Fat-Scat-21m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 97 | 53 | 3 | 6fff45d4c4bbd81a67e1ad12b131cfe6a5ab37e6 | |
| Drug | 4-hydroxyproline | 8.54e-08 | 91 | 55 | 6 | CID000000825 | |
| Drug | hydantoin-5-propionic acid | 1.77e-07 | 21 | 55 | 4 | CID000000782 | |
| Drug | AZFd | 2.61e-07 | 23 | 55 | 4 | CID000196489 | |
| Drug | AC1LAKND | 3.98e-07 | 62 | 55 | 5 | CID000470146 | |
| Drug | BAPN | 7.88e-07 | 71 | 55 | 5 | CID000001647 | |
| Drug | GK-101 | 1.69e-06 | 36 | 55 | 4 | CID000161853 | |
| Drug | Vistar | 1.69e-06 | 36 | 55 | 4 | CID000040896 | |
| Drug | halofuginone lactate | 1.93e-06 | 85 | 55 | 5 | CID000062891 | |
| Drug | 2-chlorodideoxyadenosine | 3.51e-06 | 43 | 55 | 4 | CID000072194 | |
| Drug | Madecassol | 4.61e-06 | 46 | 55 | 4 | CID000108062 | |
| Drug | ticlopidine | 4.99e-06 | 103 | 55 | 5 | CID000005472 | |
| Drug | PKI166 | 5.48e-06 | 48 | 55 | 4 | CID006918403 | |
| Drug | HgCl | 5.96e-06 | 49 | 55 | 4 | CID000024182 | |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | 6.06e-06 | 188 | 55 | 6 | 1176_DN | |
| Drug | foscarnet | 6.44e-06 | 190 | 55 | 6 | CID000003414 | |
| Drug | d-indobufen | 6.46e-06 | 50 | 55 | 4 | CID000044562 | |
| Drug | hydroxylysine | 6.59e-06 | 109 | 55 | 5 | CID000001029 | |
| Drug | ridogrel | 7.57e-06 | 52 | 55 | 4 | CID005362391 | |
| Drug | NSC49633 | 8.17e-06 | 53 | 55 | 4 | CID000023340 | |
| Drug | AC1L9732 | 8.21e-06 | 114 | 55 | 5 | CID000439300 | |
| Drug | Tranilast sodium | 8.57e-06 | 115 | 55 | 5 | CID000005527 | |
| Drug | azafagomine | 1.09e-05 | 57 | 55 | 4 | CID011957435 | |
| Drug | pirfenidone | 2.07e-05 | 138 | 55 | 5 | CID000040632 | |
| Drug | thioglycolate | 2.09e-05 | 67 | 55 | 4 | CID000001133 | |
| Drug | DL-penicillamine | 2.15e-05 | 139 | 55 | 5 | CID000004727 | |
| Drug | PCR 4099 | 2.15e-05 | 139 | 55 | 5 | CID000002806 | |
| Drug | SU6668 | 2.48e-05 | 70 | 55 | 4 | CID000206042 | |
| Drug | malotilate | 2.63e-05 | 71 | 55 | 4 | CID000004006 | |
| Drug | p11-13 | 3.26e-05 | 75 | 55 | 4 | CID000015759 | |
| Drug | AC1NMZ1B | 3.26e-05 | 75 | 55 | 4 | CID005034185 | |
| Drug | strontium ranelate | 3.62e-05 | 77 | 55 | 4 | CID006918182 | |
| Drug | khellin | 5.79e-05 | 171 | 55 | 5 | CID000003828 | |
| Drug | silibinin | 6.32e-05 | 285 | 55 | 6 | CID000005213 | |
| Drug | AC1L1DD6 | 7.19e-05 | 179 | 55 | 5 | CID000002299 | |
| Drug | bipy | 8.94e-05 | 97 | 55 | 4 | CID000001474 | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; HL60; HT_HG-U133A | 1.08e-04 | 195 | 55 | 5 | 2425_UP | |
| Drug | Gibberellic acid [77-06-5]; Up 200; 11.6uM; HL60; HT_HG-U133A | 1.16e-04 | 198 | 55 | 5 | 2910_UP | |
| Drug | 2-oyl | 1.22e-04 | 105 | 55 | 4 | CID000657137 | |
| Drug | AC1L1C2F | 1.45e-04 | 110 | 55 | 4 | CID000001711 | |
| Drug | PPACK | 1.61e-04 | 113 | 55 | 4 | CID003036757 | |
| Drug | carbonyl sulfide | 1.79e-04 | 116 | 55 | 4 | CID000010039 | |
| Drug | AC1Q6PCP | 2.32e-04 | 230 | 55 | 5 | CID000005267 | |
| Drug | Selara | 2.38e-04 | 125 | 55 | 4 | CID000150310 | |
| Drug | DMSe | 2.93e-04 | 132 | 55 | 4 | CID000020796 | |
| Disease | collagen disease (implicated_via_orthology) | 9.96e-07 | 12 | 50 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | benign familial hematuria (is_implicated_in) | 2.81e-06 | 2 | 50 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Alport syndrome, recessive type | 2.81e-06 | 2 | 50 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 2.81e-06 | 2 | 50 | 2 | C2931253 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 2.81e-06 | 2 | 50 | 2 | C4746745 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 2.81e-06 | 2 | 50 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 2.81e-06 | 2 | 50 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 2.81e-06 | 2 | 50 | 2 | cv:C0241908 | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 8.43e-06 | 3 | 50 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Alport syndrome | 8.43e-06 | 3 | 50 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 8.43e-06 | 3 | 50 | 2 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 1.68e-05 | 4 | 50 | 2 | C0241908 | |
| Disease | Alport Syndrome | 1.68e-05 | 4 | 50 | 2 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 2.80e-05 | 5 | 50 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 2.80e-05 | 5 | 50 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 2.80e-05 | 5 | 50 | 2 | C1567744 | |
| Disease | hypertensive nephropathy | 4.20e-05 | 6 | 50 | 2 | C0848548 | |
| Disease | myopathy (implicated_via_orthology) | 7.50e-05 | 48 | 50 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Connective Tissue Diseases | 2.17e-04 | 13 | 50 | 2 | C0009782 | |
| Disease | Renal glomerular disease | 6.96e-04 | 23 | 50 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 6.96e-04 | 23 | 50 | 2 | C4521256 | |
| Disease | corneal topography | 8.47e-04 | 109 | 50 | 3 | EFO_0004345 | |
| Disease | Drugs used in diabetes use measurement | 9.18e-04 | 255 | 50 | 4 | EFO_0009924 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AKPGPPDGRKGSPCG | 96 | O95936 | |
| RGPKGDLGRPGPKGT | 276 | Q14050 | |
| KPAPEARGLKGPGTP | 61 | Q15744 | |
| KGERGVKGLTGPPGP | 226 | Q01955 | |
| PCGPRGKPGKDGKPG | 1386 | Q01955 | |
| GRRGKAGLRGPPGPP | 61 | Q86Z23 | |
| GRPDSAPGKPGKPGS | 426 | P53420 | |
| GPAAPPGDKGRLRPA | 136 | Q9NRK6 | |
| KKPRDLFGPPGPPGA | 96 | Q5T7M4 | |
| DPGPPGGAPEKRRVG | 176 | Q9NUG4 | |
| EKGEPGKPGPRGKPG | 276 | P02462 | |
| KRGPSSRSGGPPPKK | 151 | P0DJD3 | |
| KRGPSSRSGGPPPKK | 151 | A6NDE4 | |
| KRGPSSRSGGPPPKK | 151 | P0DJD4 | |
| KRGPSSRSGGPPPKK | 151 | P0C7P1 | |
| KRGPSSRSGGPPPKK | 151 | A6NEQ0 | |
| KRGPSSRSGGPPPKK | 151 | Q15415 | |
| GGGLPPELPPRRGKP | 421 | Q8IY67 | |
| GIPEPPEPKRRKYGG | 826 | P98175 | |
| GRPPKPLGGGTPKEE | 1291 | Q9NTI5 | |
| PDAKSPKTGGRAPPG | 6 | P48382 | |
| RGPPKGILLFGPPGT | 431 | Q6PIW4 | |
| GKPPGKPSSEPGRRE | 1081 | Q9HCH0 | |
| LSGDGDPPKPERKGP | 1191 | Q96Q04 | |
| GKGGQGPPTRKPPRR | 636 | Q9NQC1 | |
| PPTKGLRKEERPGPG | 241 | Q6PJ61 | |
| PAGPPGKRGKRGRRG | 121 | Q9BXS0 | |
| MPPPAKEGGRKGPRE | 1 | Q8TD35 | |
| SGKGPGNPRPKAPRK | 216 | Q8IV32 | |
| KGLEGRGLPCTPKPP | 1336 | Q14674 | |
| GPKGDPGRPGKPGPR | 76 | Q7Z5L3 | |
| ARKGDIGPRGPPGIP | 726 | Q14993 | |
| MHKRKGPPGPPGRGA | 1 | Q6P1N0 | |
| KEEKKGGPPGRGPPG | 156 | Q5T5N4 | |
| GPRGERGPKGRPGPR | 141 | P05997 | |
| RGPKGRPGPRGPQGI | 146 | P05997 | |
| GKRGLPGPQGPRGDK | 1116 | P05997 | |
| KGSDKRRGGPPGPPI | 1026 | Q04637 | |
| PKGPPSPGRSRRGKT | 531 | Q12852 | |
| GEPSPKRPRGRPKGS | 41 | P52926 | |
| KPRGCSKPPWRPPGG | 206 | Q96E40 | |
| RPGPGPGVPPKRARG | 6 | P28340 | |
| VAGGPVTPRKGPPKF | 16 | P18545 | |
| PKRRRGPGGTLPGPA | 366 | Q96J94 | |
| IGGAGPPLGLPKPKK | 126 | Q92733 | |
| SPRKGAAPAPPGKTG | 381 | Q13428 | |
| TPRRGPPSEAGGGKP | 296 | Q9H4M7 | |
| GKHRPEEGPPGPLGR | 1171 | Q92835 | |
| PGPRLGPGKPGLKFN | 201 | Q16637 | |
| AGEPGRPGTKPPKRD | 931 | O15047 | |
| PGPRRPERGPRGKGK | 321 | P08913 | |
| PALAPAKPGGPGRPR | 686 | Q9H2X0 | |
| PPPKPRLKSGGGFGP | 36 | Q9H4L4 | |
| GRGGEPPPLFGKKDP | 211 | O15417 | |
| LKSEPKPPGPGAGLG | 891 | Q5TCY1 | |
| LRPKQPPGRGLGPGR | 1206 | Q5TCY1 | |
| KGAPAKARPRPPGGS | 116 | O15370 | |
| GGRPEPGPRGFVPQK | 16 | Q14997 | |
| AGRRGGKRPKPPPGV | 396 | Q9UFB7 | |
| EPIPKGSRPGGSPRG | 256 | Q96JG9 |